CAS 102767-28-2: Levetiracetam

Description:Levetiracetam is an antiepileptic drug primarily used to treat epilepsy and seizures. It is classified as a pyrrolidine derivative and is known for its unique mechanism of action, which involves binding to the synaptic vesicle protein 2A (SV2A), thereby modulating neurotransmitter release. Levetiracetam is characterized by its high solubility in water and moderate lipophilicity, which facilitates its absorption and distribution in the body. The compound has a molecular formula of C8H14N2O2 and a relatively low molecular weight. It is typically administered in the form of tablets, oral solution, or intravenous injection, allowing for flexible dosing options. Levetiracetam is generally well-tolerated, with a side effect profile that may include dizziness, fatigue, and behavioral changes. Importantly, it does not require routine monitoring of blood levels, making it a convenient option for many patients. Its efficacy in controlling partial-onset seizures and its favorable pharmacokinetic properties contribute to its widespread use in clinical practice.

Formula:C₈H₁₄N₂O₂

InChI:InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1

InChI key:InChIKey=HPHUVLMMVZITSG-LURJTMIESA-N

SMILES:O=C(N)C(N1C(=O)CCC1)CC

Synonyms:
(2S)-2-(2-oxopyrrolidin-1-yl)butanamide
(S)-1-pyrrolidineacetamid
1-Pyrrolidineacetamide, α-ethyl-2-oxo-, (S)-
Etiracetamum [INN-Latin]
(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
LEVITIRACETAM
1-Pyrrolidineacetamide, α-ethyl-2-oxo-, (αS)-
Keppra
(s)-2-(2-oxopyrrolidin-1-yl)butanamide
alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
See more synonyms
1-Pyrrolidineacetamide
UCB-L 059
Levetiracetamum [INN-Latin]
UCB-6474
UCB-L 059
alpha-ethyl-2-oxo-
Levetiracetam
(αS)-α-Ethyl-2-oxo-1-pyrrolidineacetamide
UCB 6474
Name:(S)-2-(2-Oxopyrrolidin-1-yl)butanamide (Levetiracetam)
(2R)-2-(2-oxopyrrolidin-1-yl)butanamide
Levetiracetame
Levetiracetam [INN]
(+-)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide

Found 19 products.

Product data	Purity	Price range	Estimated delivery
Levetiracetam CRS REF: 41-Y0001253CAS: 102767-28-2	- - -	115.00 €	Fri 11 Apr 25
Levetiracetam REF: 45-1359404CAS: 102767-28-2	- - -	633.00 €	Mon 14 Apr 25
Levetiracetam REF: TM-T0192CAS: 102767-28-2	98.37% - 99.67%	54.00 €~244.00 €	Tue 15 Apr 25
1-Pyrrolidineacetamide, α-ethyl-2-oxo-, (αS)- REF: IN-DA0008BRCAS: 102767-28-2	98%	25.00 €~519.00 €	Tue 15 Apr 25
Levetiracetam REF: 4Z-L-051CAS: 102767-28-2	- - -	To inquire	Mon 14 Apr 25
Levetiracetam REF: 54-OR1030439CAS: 102767-28-2	98%	32.00 €~2,087.00 €	Mon 14 Apr 25
Levetiracetam REF: 54-BUP17814CAS: 102767-28-2	99.8%	203.00 €~1,450.00 €	Mon 14 Apr 25
Levetiracetam REF: 7W-GP1133CAS: 102767-28-2	≥ 98.0% (anhydrous basis)	45.00 €~176.00 €	Mon 14 Apr 25
Levetiracetam-d6 (2,3,3,4,4,4-butyramide-d6) [2(S)-(2-Oxopyrrolidin-1-yl)butyramide] REF: 3U-D7571CAS: 102767-28-2 1133229-29-4	97 atom % D	1,655.00 €~2,778.00 €	Tue 15 Apr 25
Levetiracetam REF: 86-MM1372.00-0250CAS: 102767-28-2	- - -	1,592.00 €	Wed 16 Apr 25
Levetiracetam REF: 04-C14629710CAS: 102767-28-2	- - -	To inquire	Wed 16 Apr 25
Levetiracetam REF: AC-46212CAS: 102767-28-2	- - -	76.00 €~218.00 €	Wed 16 Apr 25
Levetiracetam REF: 3B-L0234CAS: 102767-28-2	>98.0%(HPLC)(N)	68.00 €~191.00 €	Wed 16 Apr 25
Levetiracetam Impurity 10 REF: 4Z-L-0515CAS: 102767-28-2	- - -	To inquire	Tue 22 Apr 25
Levetiracetam-d3 (contains d0) REF: TR-L331504CAS: 102767-28-2	- - -	371.00 €~2,477.00 €	Wed 23 Apr 25
Levetiracetam REF: TR-L331500CAS: 102767-28-2	- - -	116.00 €~333.00 €	Wed 23 Apr 25
(S)-2-(2-Oxopyrrolidin-1-yl)butanamide REF: 10-F079444CAS: 102767-28-2	95.0%	To inquire	Wed 23 Apr 25
Levetiracetam REF: 3D-FL24879CAS: 102767-28-2	Min. 97.5 Area-%	63.00 €~911.00 €	Thu 24 Apr 25
Levetiracetam - Bio-X ™ REF: 3D-BL164623CAS: 102767-28-2	Min. 95%	147.00 €	Thu 24 Apr 25